Literature DB >> 23285372

Osteonecrosis caused by Bisphosphonates: a clinical case.

D Spinelli1, G DE Vico, M Bonino, A Barlattani, P Bollero, A Barlattani.   

Abstract

The osteonecrosis of the maxillares caused by bisphosphonates (OMB) either wrongly known or not reconised in earlier times became nowadays very important among the dentists and maxillo-facials surgeons because of the potential serious consequences that might bring in the oral cave of the patients, who are suffering already for their base condition. The goal of our work was to verify if a deep treatment and an attentive observation with a close follow-up can bring to the resolution of serious cases of ostenecrosis of the maxillares by bisphosphonantes. Although without a statistic value our case report put the basis for a chance to execute wider casistic studies.

Entities:  

Keywords:  bisphosphonates; osteonecrosis

Year:  2010        PMID: 23285372      PMCID: PMC3415338     

Source DB:  PubMed          Journal:  Oral Implantol (Rome)        ISSN: 1974-5648


  20 in total

Review 1.  Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases.

Authors:  Jose V Bagan; Yolanda Jimenez; Judith Murillo; Sergio Hernandez; Rafael Poveda; José M Sanchis; José M Diaz; Crispian Scully
Journal:  Oral Oncol       Date:  2005-11-04       Impact factor: 5.337

2.  Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.

Authors:  E Merigo; M Manfredi; M Meleti; D Corradi; P Vescovi
Journal:  J Oral Pathol Med       Date:  2005-11       Impact factor: 4.253

3.  Osteonecrosis of the jaw associated with pamidronate therapy.

Authors:  Ryan Zarychanski; Erin Elphee; Paul Walton; James Johnston
Journal:  Am J Hematol       Date:  2006-01       Impact factor: 10.047

4.  Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy.

Authors:  M Sato; W Grasser
Journal:  J Bone Miner Res       Date:  1990-01       Impact factor: 6.741

5.  Pamidronate induces modifications of circulating angiogenetic factors in cancer patients.

Authors:  Daniele Santini; Bruno Vincenzi; Giuseppe Avvisati; Giordano Dicuonzo; Fabrizio Battistoni; Michele Gavasci; Alfredo Salerno; Vincenzo Denaro; Giuseppe Tonini
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

6.  Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: a case report.

Authors:  W J Starck; B N Epker
Journal:  Int J Oral Maxillofac Implants       Date:  1995 Jan-Feb       Impact factor: 2.804

Review 7.  Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.

Authors:  Sook-Bin Woo; John W Hellstein; John R Kalmar
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

8.  Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption.

Authors:  C Vitté; H Fleisch; H L Guenther
Journal:  Endocrinology       Date:  1996-06       Impact factor: 4.736

9.  Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients--a report of a thirty year retrospective review.

Authors:  T Reuther; T Schuster; U Mende; A Kübler
Journal:  Int J Oral Maxillofac Surg       Date:  2003-06       Impact factor: 2.789

10.  Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.

Authors:  D E Hughes; B R MacDonald; R G Russell; M Gowen
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.